金日品牌怎么样 申请店铺

我要投票 金日在保健养生行业中的票数:291 更新时间:2025-02-24
金日是哪个国家的品牌?金日,是一家有二十多年历史,集制药、医疗、保健、食品、金融、贸易、房地产为一体的多元化实业集团,拥有香港及内地十几家下属企业,并在新加坡、加拿大等地进行各类投资贸易活动,已在国内厦门、福州、顺德、深圳

外推网助力金日品牌出海!通过在本页面挂载金日品牌的产品链接和联系邮箱,可以提高金日产品曝光!跨境电商爆单神器,目前只要100元/年哦~

金日怎么样

金日,是一家有二十多年历史,集制药、医疗、保健、食品、金融、贸易、房地产为一体的多元化实业集团,拥有香港及内地十几家下属企业,并在新加坡、加拿大等地进行各类投资贸易活动,已在国内厦门、福州、顺德、深圳等地设立制造基地。

金日制药(中国)有限公司作为金日集团全资子公司,成立于1991年,是集团健康产业在国内的主要生产基地,是一家集研发、生产和销售为一体的现代化制药企业。经过数十年不懈的努力,公司产品从单一的洋参丸,发展到目前胶囊剂、片剂、口服液、冲剂、膏剂、凝胶剂、膜剂等12条生产线近百个品种,产品畅销不滞,深受广大消费者的青睐,成为福建省具规模的现代化药品及保健品生产企业。

20多年的品牌建设,已使“金日牌”系列产品享誉海内外,“金日洋参”已成为中国洋参行业品牌,公司自主研发、生产的“金日牌心源素胶囊”深受中国心脑健康患者的喜爱。

金日制药(中国)有限公司不仅拥有历史悠久的品牌、拥有雄厚的资金实力、拥有专业的管理人才、拥有完善的产业化基础、更拥有强大的新产品研发能力。仅在厦门一地就有研发技术人员56人,其中博士研究生1人,硕士5人,高级工程师7人,工程师39人。  金日制药(中国)有限公司在加大自主研发力度的基础上,与中国药科大学、上海中医药大学、北京大学、南京中医药大学、福建中医药大学、江西中医学院、东南大学、华中科技大学、同济医学院、第四军医大学西京医院等国内外多家科研机构、学府紧密合作,获得了多项自主科研技术及核心自主知识产权。

Jinri is a diversified industrial group with a history of more than 20 years, integrating pharmacy, medical treatment, health care, food, finance, trade and real estate. It has more than a dozen subordinate enterprises in Hong Kong and the mainland, and carries out various investment and trade activities in Singapore, Canada and other places. It has established manufacturing bases in Xiamen, Fuzhou, Shunde, Shenzhen and other places in China. As a wholly-owned subsidiary of kingri group, kingri Pharmaceutical (China) Co., Ltd. was founded in 1991. It is the main production base of the group's health industry in China and a modern pharmaceutical enterprise integrating research and development, production and sales. After decades of unremitting efforts, our products have developed from a single ginseng pill to nearly 100 varieties of 12 production lines, such as capsules, tablets, oral liquids, granules, ointments, gels and film agents. The products are sold well without delay, and are well received by consumers and become the modern pharmaceutical and health care products manufacturers in Fujian. More than 20 years of brand building has made "Jinri brand" series products famous at home and abroad, "jinriyangshen" has become the brand of China's foreign ginseng industry, and the "Jinri brand Xinyuansu capsule" independently developed and produced by the company is deeply loved by Chinese heart and brain health patients. Jinri Pharmaceutical (China) Co., Ltd. not only has a long history of brand, has a strong financial strength, has professional management personnel, has a sound industrial foundation, but also has a strong ability of new product research and development. In Xiamen alone, there are 56 R & D technicians, including 1 doctoral candidate, 5 masters, 7 senior engineers and 39 engineers. Jinri Pharmaceutical (China) Co., Ltd., on the basis of increasing its independent research and development efforts, cooperates closely with many scientific research institutions and institutions at home and abroad, such as China Pharmaceutical University, Shanghai University of traditional Chinese medicine, Peking University, Nanjing University of traditional Chinese medicine, Fujian University of traditional Chinese Medicine, Jiangxi University of traditional Chinese medicine, Southeast University, Huazhong University of science and technology, Tongji Medical College, Xijing Hospital of the Fourth Military Medical University, etc And obtained a number of independent scientific research technologies and core independent intellectual property rights.

本文链接: https://brand.waitui.com/db89dd4f3.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

2025年中央一号文件发布

36氪获悉,2025年中央一号文件2月23日发布,《中共中央 国务院关于进一步深化农村改革 扎实推进乡村全面振兴的意见》提出,以改革开放和科技创新为动力,巩固和完善农村基本经营制度,深入学习运用“千万工程”经验,确保国家粮食安全,确保不发生规模性返贫致贫,提升乡村产业发展水平、乡村建设水平、乡村治理水平,千方百计推动农业增效益、农村增活力、农民增收入,为推进中国式现代化提供基础支撑,这是党的十八大以来第13个指导“三农”工作的中央一号文件。

2小时前

海天味业:公司发行H股备案申请材料获中国证监会接收

36氪获悉,海天味业公告称,公司已于2025年1月13日向香港联交所递交了发行H股股票并在香港联交所主板挂牌上市的申请。公司已向中国证监会报送了关于公司本次发行的备案申请材料并于近日获中国证监会接收。该事项仍存在不确定性,公司将根据进展情况及时履行信息披露义务。

2小时前

山河药辅:股东复星医药拟减持不超过3%公司股份

36氪获悉,山河药辅发布公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。

2小时前

镁伽科技正式推出LABILLION™实验室智慧管理平台,并于线上发布

36氪获悉,近日镁伽科技正式推出LABILLION™实验室智慧管理平台,并于线上发布。作为镁伽在“AI for Science(AI4S)”领域的新成果,LABILLION™以AI与自动化技术为核心,针对生命科学研发中长期存在的数据孤岛、系统僵化、流程低效等痛点,为科学家提供从实验设计到数据分析的全链路智能支持,助力科研创新效率的提升。

2小时前

本页详细列出关于森山的品牌信息,含品牌所属公司介绍,森山所处行业的品牌地位及优势。
咨询